Podcasts about us pharmacopeia

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Private equity firms Blackstone and Bain Capital are close to finalizing a potential $3 billion deal for Mitsubishi's pharma unit, Mitsubishi Tanabe Pharma. In other news, five drugs have been flagged for unjustified price hikes in 2023 by the Institute for Clinical and Economic Review. Incyte and Iteos are cutting drug candidates from their cancer pipelines due to disappointing data, while the FDA advisory committee has called for more research on Moderna's RSV vaccine after safety issues arose. Layoffs have been announced at Intercept and Editas, and there has been a slowdown in M&A activity in the pharma industry this year. US Pharmacopeia is looking for expert volunteers to work on medicine quality challenges.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.J&J and Legend have released new Phase III data for their drug Carvykti, showing nearly 90% of patients had no detectable cancer cells after treatment. This data could help them fend off competition from emerging CAR T therapies like Gilead and Arcellx's Anito-cel. Biontech also has promising breast cancer data for their drug BNT327, while Moderna's RSV vaccines are facing safety concerns. Meanwhile, there is pushback against IRA's controversial 'pill penalty'. Opportunities to become a US Pharmacopeia expert volunteer are available. In the biotech industry, Acelyrin terminated its drug Izokibep after failed Phase IIB/III data, Cellectar downsized by 60%, and M&A spending has been small this year.Pharma dealmaking in 2024 has mostly stayed under $5 billion, with the exception of Novo Holdings' acquisition of Catalent for $16.5 billion. The proposed EPIC Act, which aims to give small molecule drugs the same protection against price negotiation as biologics, faces challenges due to concerns over balancing the federal budget. The biotech IPO class of 2024 has struggled, with many companies tumbling from their original offer price after going public. Novo and Catalent's deal has received EU approval, Lilly is investing $3 billion in a Wisconsin site, and GSK is making agreements to further their presence in neurology. Carisma Therapeutics is cutting staff and reprioritizing their pipeline, while Relmada is exploring strategic alternatives after a failed asset in depression. Cellectar is downsizing by 60% as they explore options for their cancer drug.

Send us a Text Message.The supplement industry is a vast, nearly $200 billion global market that varies widely in quality, benefit, and risks. While supplements can significantly aid in achieving health goals such as improving fitness, rebalancing nutrient deficiencies, and eliminating harmful microbes, they are not a cure-all solution. It's crucial to use them strategically and aim to reduce dependence on them over time.Choosing the right supplements is essential, as low-quality products can be ineffective or even harmful. Consumer-grade supplements, often found in local stores and online, may contain proprietary blends, synthetic nutrients, fillers, and hidden ingredients that are inconsistently dosed and potentially contaminated. On the other hand, pharmaceutical-grade supplements, available through reputable suppliers, are stringently tested for purity, bioavailability, and accurate dosing, ensuring a higher and safer quality.When purchasing supplements online, it's important to buy directly from manufacturers or verified suppliers to avoid counterfeit products. Third-party certifications such as NSF, Non-GMO Project Verified, and US Pharmacopeia can help identify high-quality supplements. Remember, supplements should be used as necessary, much like medications, to support the body's natural healing processes.Where I buy my supplements: Fullscript: quality supplements, personal care products, and nutritional foods (check out my favorites inside the store)https://us.fullscript.com/welcome/andreanicholsonUnicity: natural GLP-1 stimulating and gut repair food products. I love the Feel Great System: Unimate lemon and the Balance orange.https://ufeelgreat.com/c/andreaDid you know my practice is entirely virtual? You don't have to live near me to get help with fatigue, stubborn weight, hypertension, prediabetes or more?Schedule a free call Free Metabolic Mastery ManualFree Facebook Community

Tieraona Low Dog, MD, ABOIM and Ashley Koff, RD, join Integrative Practitioner Content Specialist Avery St. Onge to discuss how to navigate personalized nutrition in an era where practitioners and their patients are overloaded with contradictory information and data from social media and direct-to-consumer products. This episode is brought to you by the Integrative Healthcare Symposium. Register for the Symposium and receive 15% off with promo code IPpodcast: https://www.xpressreg.net/register/ihsy0224/landing.php?sc=IPpodcast Learn more about the event by visiting the Symposium website: www.ihsymposium.com Contact the Integrative Healthcare Symposium team: info@ihsymposium.com Find us at integrativepractitioner.com or e-mail us at IPEditor@divcom.com. Theme music: "Upbeat Party" by Scott Holmes via freemusicarchive.org, "Carefree" by Kevin Mcleod via incompetech.com, and “Relaxing Light Background” by AudioCoffee. About the Experts Tieraona Low Dog, MD, ABOIM is a leading expert and thought leader in the fields of botanical medicine, dietary supplements, and Integrative Medicine. During her 40-year career, she has led two Integrative Medicine fellowships, chaired five expert panels at the US Pharmacopeia, received a presidential appointment under Bill Clinton, published 50+ peer-reviewed articles, written seven books (four with National Geographic), received an honorary doctorate in naturopathic medicine from Bastyr University, was honored as Time Magazine's Innovator of the Year, and is a recipient of four Lifetime Achievement Awards, and three Awards for Excellence in Science and Public Health. She has been an invited speaker to more than 600 science/medical conferences. In addition to her medical degree, Dr. Low Dog has been trained in midwifery, massage therapy, and holds a 3rd degree black belt in Tae Kwon Do. Ashley Koff RD is a 25+ year personalized nutrition expert. Renowned for her ability to translate nutrition science into deliciously doable recommendations, Koff is a longstanding advisor, educator and strategic consultant for the media, practitioners, businesses, and organizations. Today, as the founder of The Better Nutrition Program, Koff helms a team of clinicians, coaches, and experts to create and implement personalized health solutions at scale. She lives in Maine, plays the trumpet, loves hiking and dogs, is a connector, optimist, and humanitarian. For more information, please visit TheBetterNutritionProgram.com

The Gentleman brings you up to speed on the US Pharmacopeia's plan to issue medical cannabis guidelines, why a major alcohol industry association has thrown its support behind federal legalization, and the first license granted to grow psilocybin in the US. Plus! This episode our guest Reba "The Diva" Thomas, owner & founder of Sexpert Consultants, will offer you advice for spicing up your bedroom with sinsemilla, psychedelics, and cannabinoid-infused lubes.

Welcome to “Analytically Speaking,” the podcast from LCGC and Spectroscopy. Here in Episode 13, podcast host Dr. Jerry Workman talks to Dr. Paul C. DeRose, who is a senior research chemist at the National Institute of Standards and Technology (NIST) and leads the NIST Biochemical Science Division's project in luminescence standards development for chemical analysis and assay validation. We spoke to Paul about his current research interests in fluorescence and luminescence spectroscopy, specifically concerning the development of fluorescence standards and methods for validation of chemical and clinical assays. Paul's research has resulted in publications in various areas of fluorescence spectroscopy and microscopy. He has developed fluorescence standard guidelines and recommendations for ASTM, IUPAC, and the US Pharmacopeia. He is also the chair of ASTM E13.01.01 sub-committee on Molecular Luminescence.

In 2020, the enormously popular heartburn medication Zantac was pulled from store shelves after samples were found to contain the probable carcinogen NDMA. The drug has since been re-introduced with a new formula that is considered safe to use as directed.But tens of thousands of people who took the old version of the drug, made with the active ingredient ranitidine, are now suing Zantac's maker, then called Glaxo and now known as GSK. They claim the medication gave them cancer and are seeking compensation. The company is pushing back, saying there is no conclusive evidence or scientific consensus that ranitidine can degrade and form NDMA in harmful amounts under normal conditions.Reporters Anna Edney, Susan Berfield, and Jef Feeley dug into the claims and counterclaims for Bloomberg Businessweek, and they join this episode to talk about Zantac's rise and fall and where these lawsuits are headed. And Dr. Jaap Venema, chief science officer at US Pharmacopeia, explains how potential carcinogens get into drugs–and what pharmaceutical companies and government agencies are–and should be–doing to ensure the safety of the medications we take. Read the story: https://bloom.bg/3Yxzno2 Listen to The Big Take podcast every weekday and subscribe to our daily newsletter: https://bloom.bg/3F3EJAK  Have questions or comments for Wes and the team? Reach us at bigtake@bloomberg.net.See omnystudio.com/listener for privacy information.

Hi Everyone, You receive a phone call at 2am from a junior colleague who tells you that they are managing a code blue caesarean section and in the confusion of urgently administering a number of different medications they have just accidentally injected 10ml of cephazolin into the epidural catheter instead of the intravenous tubing. They are understandably upset and worried. (* This is a hypothetical scenario). What are wrong route errors? How common are they? How do they happen? Article from 2012 - "The US Pharmacopeia, the largest information source of tube misconnection related errors, has received 1600 reports of epidural to central or peripheral intravenous misconnections since 1999." What is NRFIT and how will this help improve patient safety? When is it coming? - It is already here and will probably coming to your health service soon. Many hospitals around the world including all of Japan have already changed over and a few sites in Australia / NZ have also now introduced NRFIT. Join Graeme and I as we discuss the issue of wrong route errors, and what you need to know about NRFIT, as well of course a few bad Xmas jokes! LINKS Reducing Risk of Epidural-Intravenous Misconnections - APSF Newsletter Winter 2012 Challenges when introducing NRFit™ at a tertiary hospital in Japan International Journal of Obstetric Anesthesia, 2022-02-01, Volume 49, Article 103244 . This article is behind Elseviers firewall but you should be able to access it through the ANZCA library or your own hospitals if you are lucky enough to have these available. NRFIT Pajunk Stay connected GEDSA NRFIT website

Kurt speaks with Amanda Diffenderfer, Senior Digital Campaigns Manager at US Pharmacopeia. Amanda talks about how you don't have to target everyone at one time, rather you go where you have wins and spend your money there.

In this episode, we look at why vitamins are an important part of life. But be careful, they aren't always what they seem. Hosted By: Gregg Clunis | https://www.instagram.com/greggclunis/ Instagram: http://instagram.com/tinyleaps Twitter: http://twitter.com/tinyleaps Website: http://tlbc.co/tiny-leaps-big-changes Resources: National Institute on Aging. (2021). Vitamins and Minerals for Older Adults. US Department of Health and Human Services. Retrieved from https://www.nia.nih.gov/health/vitamins-and-minerals-older-adults. Katie Forster. (2017). Multivitamins Just Create ‘Very Expensive Urine,’ Medical Chief Warns. Independent. Retrieved from https://www.independent.co.uk/life-style/health-and-families/health-news/multivitamins-expensive-urine-waste-money-vitamins-australian-medical-association-chief-michael-gannon-supplements-a7578961.html. Centers for Disease Control. (2018). CDC’s Second Nutrition Report: A comprehensive biochemical assessment of the nutrition status of the US population. Retrieved from https://www.cdc.gov/nutritionreport/pdf/4page_%202nd%20nutrition%20report_508_032912.pdf. UnityPoint. (2020). How to Spot a Vitamin D Deficiency. UnityPoint Health LiveWell. Retrieved from https://www.unitypoint.org/livewell/article.aspx?id=ca7f4766-8ba8-43a2-bbe7-0ef9efab5c6d. Harvard Health Publishing. (2020). Vitamin B12 Deficiency Can Be Sneaky, Harmful. Harvard Health Publishing Harvard Medical School. Retrieved from https://www.health.harvard.edu/blog/vitamin-b12-deficiency-can-be-sneaky-harmful-201301105780. Food and Drug Administration. (2017). What You Need to Know about Dietary Supplements. FDA. Retrieved from https://www.fda.gov/food/buy-store-serve-safe-food/what-you-need-know-about-dietary-supplements. National Health Service. (2020). Vegetarian and vegan diets. NHS. Retrieved from https://www.nhs.uk/live-well/eat-well/vegetarian-and-vegan-diets-q-and-a/#:~:text=Vitamin%20B12%20is%20only%20found,is%20fortified%20with%20vitamin%20B12. United States Pharmacopeia. (2020). What is the US Pharmacopeia? Retrieved from https://qualitymatters.usp.org/what-us-pharmacopeia. --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app

Ronald Piervincenzi, CEO of US Pharmacopeia on pharma supply chain & more * VADM John Bird (Ret) of USAA on Memorial Day and PoppyInMemory.com * Fmr State Sen Greg Brophy on the pros and cons of mail-in voting * CO State Rep Colin Larson (R-HD22) has a plan to reopen Colorado

Dr. Tieraoana Low Dog is an internationally recognized expert in integrative medicine, natural products and women’s health. She is a frequent lecturer, teacher, and writer of books such as Fortify Your Life, Healthy at Home, and Life is Your Best Medicine. Dr. Low Dog is a founding member of the American Board of Physician Specialties: American Board of Integrative Medicine and the Academy of Women’s Health. Given her vast experience on dietary supplements and herbal medicine, she has been elected Chair for numberous dietary supplements and botanical panels for the US Pharmacopeia for more than 15 years, as well as numerous other awards and appointments in her illustrious career. Dr. Low Dog shares insight not only as a gifted healer and educator, but also as someone who has been diagnosed with advanced cancer years ago. In this second part, we discuss symptom management and women’s health related to cancer. Dr. Low Dog also talks about her journey through cancer and what it taught her about life, health, and healing.

Dr. Tieraoana Low Dog is an internationally recognized expert in integrative medicine, natural products and women’s health. She is a frequent lecturer, teacher, and writer of books such as Fortify Your Life, Healthy at Home, and Life is Your Best Medicine. Dr. Low Dog is a founding member of the American Board of Physician Specialties: American Board of Integrative Medicine and the Academy of Women’s Health. Given her vast experience on dietary supplements and herbal medicine, she has been elected Chair for numberous dietary supplements and botanical panels for the US Pharmacopeia for more than 15 years, as well as numerous other awards and appointments in her illustrious career. Dr. Low Dog shares insight not only as a gifted healer and educator, but also as someone who has been diagnosed with advanced cancer years ago. In this first part, we discuss the use of natural products and other insights Dr. Low Dog has for those affected by cancer.

Sue Ceglinski is the Global Head of TA for US Pharmacopeia, the organization that develops and disseminates public quality standards for medicines, vitamins, and foods, setting standards to keep millions of people safe and healthy globally. We talk about the quirky start to her career as a Physician Recruiter, and how she has evolved to lead large and small TA Teams over time by being humble, curious, and willing to focus on the long-term mission.

Despite being legal in more than half the states of the US, cannabis, and hemp are still federally illegal and considered to have no medical benefit by the US government and listed as a Schedule 1 substance under the Controlled Substance Act. As it stands, farmers face several barriers to grow cannabis and hemp due to federal prohibition — including restricted access to banking, water rights, and crop insurance.   This history of hemp and cannabis is incredible and dates back to 1619 with our founding fathers.  In 1850, cannabis was added to US Pharmacopeia as a treatment for numerous afflictions, including tetanus, alcoholism, opiate addiction, anthrax, gout, convulsive disorders, excessive menstrual bleeding, among others.   In 1933 alcohol prohibition ends, and "cannabis concerns" arise at the US Federal level. In 1934, The Garrison Act passed, which outlawed cannabis among other drugs. In 1936, medical Marijuana is replaced by other pain relievers and is removed on the US Pharmacopeia in 1937. From the 1950s-1980s, cannabis is listed as a controlled substance and the US implements very strict mandatory minimum sentences for cannabis possession.  In 1996, California was the first state to legalize medical marijuana under prop 215. In 2014, Colorado was the first state to legalize adult use of cannabis. To date, more than 30 states have legalized cannabis. 

Today, our guest is Dr. Renee Default, the author of Unsafe at Any Meal: What the FDA Does Not Want You to know About the Foods You Eat.  Amy and Dr. Benzinger sit down with Renee to discuss… - Her time as a former investigator at the FDA, why the FDA told her that she couldn’t post her findings on inorganic mercury or high fructose corn syrup, and why she made the decision to retire at the end of 2006. - The responsibilities of the FDA and the implications they have on public food safety. - The difference between US Pharmacopeia and the FDA. - How other nations can elect to take the standards established by the FDA and make them more stringent, and why the United States chooses not to. - Why some countries are starting to reject our food exports. - Pesticides in our food, and how they linked to Parkinson’s, Alzheimer’s, and a range of other issues. - Which heavy metals are allowed in food ingredients at dangerous levels and what you can do to minimize your exposure to them. - What you can do to deal with some of these issues at home. - Mercury and high fructose corn syrup. - The link between highly processed foods and type 2 diabetes.

Today on the show we welcome Stephanie Goetsch. Stephanie is the founder of Spark Career Strategy, which she launched in 2010. What began as a dedicated career coaching for "what's next" professionals, blossomed into organizational development and human resources consulting, career and performance coaching, and group training offerings. As the name suggests, Stephanie delivers both spark and strategy to each company and client that she works with. She's a lover of change, whether it's changing minds with learning, changing careers with career coaching, changing business with innovation and design, or changing behaviors with performance coaching.  Prior to launching her own business, she held a number of human resource positions in different organizations, including US Pharmacopeia and Chevy Chase Bank. She's also a passionate supporter of the US Military and in 2016 she founded Call to Action, which is a non-profit organization that delivers exceptional career transition strategies to US veterans and military spouses to successfully leverage their unique talents for civilian careers. 

Adulteration of food proteins - as seen in the recent melamine scandal - is becoming a greater threat to industry as the food supply has become more globalized and economic crisis drives manufacturers to seek cheaper ingredients, says Jim Griffiths of US Pharmacopeia.